APLS
NASDAQ
$41.03
Apellis Pharmaceuticals Inc (APLS)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$5.25B
Revenue 5Y CAGR
+34.55%
P/E Ratio
39.02
Free Cash Flow Yield
0.71%
Price Chart
Valuation
Market Cap$5.25B
P/E39.02
Forward P/E46.30
Profitability
Total Revenue (TTM)$1.11B
Gross Profit (TTM)$710M
EBITDA$167M
Profit Margin7%
Operating Margin9.9%
EPS$1.05
Financial Health
Debt-to-Equity22.6%
Free Cash Flow Yield0.71%
Growth & Risk
Revenue 5Y CAGR+34.55%
Sharpe Ratio1.03